Literature DB >> 497983

Hemodynamic monitoring and care of the patient of high risk for anesthesia.

S P Pietak, S J Teasdale.   

Abstract

Hemodynamic monitoring and care of the patient at high risk for anesthesia require a careful and systematic approach. During preoperative evaluation the patient at increased risk must be identified and correctable problems must be solved. The patient's current medications must be reviewed because they may influence the choice of anesthetic approach and may alter the physiologic response to the stresses commonly associated with anesthesia. In addition to conventional clinical and electrocardiographic monitoring, perioperative hemodynamic monitoring may be desirable for patients at special risk, who are likely to have significant associated medical problems or to undergo complicated surgical procedures. No ideal induction agent exists, and hypotension secondary to peripheral vasodilation or myocardial depression, or both, is a potential problem. Patients with an inordinately high risk may benefit from mechanical circulatory assistance prior to induction of anesthesia. Attention to oxygenation, blood volume replacement and the prevention of hypertensive episodes are particularly important during anesthesia so that optimal cardiac performance is ensured and ischemia avoided. The stresses during emergence from anesthesia contribute to lability of the cardiovascular status and hypoxemia. The period of risk does not conclude with immediate recovery from anesthesia but extends through the postoperative phase. Careful monitoring and attention to the control of pain, prevention of hypotension and hypertension, adequate oxygenation, early mobilization and resumption of the administration of cardiac medications are important factors in a successful outcome.

Entities:  

Mesh:

Year:  1979        PMID: 497983      PMCID: PMC1704486     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  21 in total

1.  Multifactorial index of cardiac risk in noncardiac surgical procedures.

Authors:  L Goldman; D L Caldera; S R Nussbaum; F S Southwick; D Krogstad; B Murray; D S Burke; T A O'Malley; A H Goroll; C H Caplan; J Nolan; B Carabello; E E Slater
Journal:  N Engl J Med       Date:  1977-10-20       Impact factor: 91.245

2.  A comparison of two bipolar exercise electrocardiographic leads to lead V5.

Authors:  V F Froelicher; R Wolthius; N Keiser; A Stewart; J Fischer; M R Longo; J H Triebwasser; M C Lancaster
Journal:  Chest       Date:  1976-11       Impact factor: 9.410

3.  Hemodynamics during general anesthesia in patients receiving propranolol.

Authors:  C J Kopriva; A C Brown; G Pappas
Journal:  Anesthesiology       Date:  1978-01       Impact factor: 7.892

Review 4.  Anesthetic agents and cardiac electromechanical activity.

Authors:  M G Pratila; V Pratilas
Journal:  Anesthesiology       Date:  1978-11       Impact factor: 7.892

5.  Propranolol and cardiac surgery.

Authors:  J F Viljoen; F G Estafanous; G A Kellner
Journal:  J Thorac Cardiovasc Surg       Date:  1972-11       Impact factor: 5.209

6.  Hazards of general anesthesia in the reserpinized patient.

Authors:  A J Ominsky; H Wollman
Journal:  Anesthesiology       Date:  1969-04       Impact factor: 7.892

7.  Studies of anaesthesia in relation to hypertension. I. Cardiovascular responses of treated and untreated patients.

Authors:  C Prys-Roberts; R Meloche; P Foëx
Journal:  Br J Anaesth       Date:  1971-02       Impact factor: 9.166

8.  Cardiovascular effects of plasma levels of thiopental necessary for anesthesia.

Authors:  K E Becker; A S Tonnesen
Journal:  Anesthesiology       Date:  1978-09       Impact factor: 7.892

9.  Safety and rationale for continuation of propranolol therapy during coronary bypass operation.

Authors:  H Boudoulas; G L Snyder; R P Lewis; R E Kates; P E Karayannacos; J S Vasko
Journal:  Ann Thorac Surg       Date:  1978-09       Impact factor: 4.330

Review 10.  The high-risk cardiac patient undergoing general surgery.

Authors:  J E Wynands
Journal:  Can J Surg       Date:  1978-11       Impact factor: 2.089

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.